John A Chmiel
Overview
Explore the profile of John A Chmiel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akouris P, Stuivenberg G, Chmiel J, Kiattiburut W, Poon A, Reid G, et al.
Gut Microbes
. 2024 May;
16(1):2350778.
PMID: 38717446
Ethanolamine is an abundant compound in the gastrointestinal tract and a valuable source of carbon and nitrogen for pathogenic bacteria harboring ethanolamine utilization () genes. -positive pathogens can consume free...
2.
Andary C, Al K, Chmiel J, Gibbons S, Daisley B, Parvathy S, et al.
Trends Mol Med
. 2024 Jan;
30(3):209-222.
PMID: 38195358
Fecal microbiota transplantation (FMT) has emerged as an alternative or adjunct experimental therapy for microbiome-associated diseases following its success in the treatment of recurrent Clostridioides difficile infections (rCDIs). However, the...
3.
Al K, Joris B, Daisley B, Chmiel J, Bjazevic J, Reid G, et al.
Microbiome
. 2023 Nov;
11(1):263.
PMID: 38007438
Background: Inquiry of microbiota involvement in kidney stone disease (KSD) has largely focussed on potential oxalate handling abilities by gut bacteria and the increased association with antibiotic exposure. By systematically...
4.
Chmiel J, Stuivenberg G, Wong J, Nott L, Burton J, Razvi H, et al.
J Endourol
. 2023 Nov;
38(8):778-787.
PMID: 37975292
Preventative strategies and surgical treatments for urolithiasis depend on stone composition. However, stone composition is often unknown until the stone is passed or surgically managed. Given that stone composition likely...
5.
Chmiel J, Carr C, Stuivenberg G, Venema R, Chanyi R, Al K, et al.
Front Microbiol
. 2023 Jun;
14:1231746.
PMID: 37378284
[This corrects the article DOI: 10.3389/fmicb.2022.1011102.].
6.
Chmiel J, Stuivenberg G, Al K, Akouris P, Razvi H, Burton J, et al.
Nat Rev Urol
. 2023 May;
20(10):615-637.
PMID: 37161031
Calcium-based kidney stone disease is a highly prevalent and morbid condition, with an often complicated and multifactorial aetiology. An abundance of research on the role of specific vitamins (B, C...
7.
Gholami H, Chmiel J, Burton J, Maleki Vareki S
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831641
Not all cancer patients who receive immunotherapy respond positively and emerging evidence suggests that the gut microbiota may be linked to treatment efficacy. Though mechanisms of microbial contributions to the...
8.
Chmiel J, Carr C, Stuivenberg G, Venema R, Chanyi R, Al K, et al.
Front Microbiol
. 2023 Jan;
13:1011102.
PMID: 36620050
is a unique bacterium with the ability to metabolize oxalate as a primary carbon source. Most kidney stones in humans are composed of calcium and oxalate. Therefore, supplementation with an...
9.
Wallace B, Chmiel J, Al K, Bjazevic J, Burton J, Goldberg H, et al.
J Endourol
. 2022 Dec;
37(3):358-366.
PMID: 36562270
The pathogenesis of infectious kidney stones is poorly understood. Bacteria have been implicated in promoting infectious stones via urease production; however, there is mounting evidence indicating the relationship is more...
10.
Akouris P, Chmiel J, Stuivenberg G, Kiattiburut W, Bjazevic J, Razvi H, et al.
Urolithiasis
. 2022 Dec;
51(1):19.
PMID: 36547746
Kidney stone disease affects nearly one in ten individuals and places a significant economic strain on global healthcare systems. Despite the high frequency of stones within the population, effective preventative...